Isaac Francis

Biome Australia (ASX:BIO) has cleared the final regulatory hurdle to begin a landmark human clinical trial for its proprietary probiotic strain, Lactobacillus plantarum BMB18.

Ore Resources (ASX:OR3) has kicked off an expansive 30,000-meter Phase 4 drilling program at its Coolgardie Gold Project.

Reserve Bank of Australia’s Monetary Policy Board announced a 25-basis point increase in the cash rate target, bringing it to 3.85%.

Xero (ASX:XRO) intensified its global growth narrative during a high-stakes investor briefing on Feb. 3, showcasing a future anchored in artificial intelligence and a revitalised US payments strategy.

Lumen Technologies (NYSE:LUMN) finalized the sale of its Mass Markets fiber-to-the-home business across 11 states to AT&T (NYSE: T) on Monday.

ImmunityBio (NASDAQ:IBRX) announced Monday the launch of ResQ215B, a Phase 2 clinical study evaluating a novel, outpatient immunotherapy combination for patients with indolent B-cell non-Hodgkin lymphoma (iNHL), including Waldenström’s Macroglobulinemia.

TransUnion (NYSE:TRU) signed a definitive agreement on Monday to acquire the mobile division of RealNetworks, a move aimed at integrating advanced artificial intelligence and machine learning into its growing communications and fraud-prevention suite.

Opera (NASDAQ:OPRA) announced on Monday that its fourth-quarter and full-year 2025 performance is expected to significantly exceed its prior financial targets.

Patria Investments (NASDAQ:PAX) reached a deal to acquire WP Global Partners on Monday, a move that significantly bolsters the firm’s presence in the U.S. lower-middle market.

XPeng (NYSE:XPEV) started the year with a surge in momentum, delivering 20,011 vehicles in January 2026 as the Chinese automaker aggressively scales its international footprint.